As per its 2015 contract with Israel’s MediWound (see here), the U.S. Department of Health (HSS), is stockpiling $16.5 million worth of MediWound’s NexoBrid burns treatment. HSS has options on another $50 million of NexoBrid.
US Government buys Israeli wound treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.